Back
BondBloxx CCC Rated USD High Yield Corp Bd ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
26
XCCC
BondBloxx CCC Rated USD High Yield Corp Bd ETF
Last Price:
$36.10
Seasonality Move:
-0.59%
Sell
17
NONOF
Novo Nordisk A/S
Last Price:
$35.59
Seasonality Move:
4.8%
Sell
26
BondBloxx CCC Rated USD High Yield Corp Bd ETF (XCCC)
is a Sell
Is BondBloxx CCC Rated USD High Yield Corp Bd ETF a Buy, Sell or Hold?
-
The current BondBloxx CCC Rated USD High Yield Corp Bd ETF [XCCC] share price is $36.11. The Score for XCCC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
XCCC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $35.59. The Score for NONOF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
XCCC Stock Price Chart
What is BondBloxx CCC Rated USD High Yield Corp Bd ETF's stock price today?
-
The BondBloxx CCC Rated USD High Yield Corp Bd ETF share price today is $36.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XCCC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $35.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
XCCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 40.52 | Sell |
| Chaikin Money Flow: | 107615 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.13 - 36.81) | Sell |
| Bollinger Bands (100): | (36.9 - 38.42) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.13 | Sell |
| Relative Strength Index (14 RSI): | 34 | Sell |
| Chaikin Money Flow: | -84014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.94 - 38.44) | Sell |
| Bollinger Bands (100): | (39.64 - 55.38) | Sell |
XCCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.15 | Sell |
| 20-day SMA: | 36.34 | Sell |
| 50-day SMA: | 37.12 | Sell |
| 200-day SMA: | 38.2 | Sell |
| 8-day EMA: | 36.17 | Sell |
| 20-day EMA: | 36.4 | Sell |
| 50-day EMA: | 36.94 | Sell |
| 200-day EMA: | 37.87 | Sell |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.83 | Sell |
| 20-day SMA: | 37 | Sell |
| 50-day SMA: | 44.15 | Sell |
| 200-day SMA: | 53.01 | Sell |
| 8-day EMA: | 35.83 | Sell |
| 20-day EMA: | 37.34 | Sell |
| 50-day EMA: | 41.96 | Sell |
| 200-day EMA: | 54.32 | Sell |
BondBloxx CCC Rated USD High Yield Corp Bd ETF Earnings Growth & XCCC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BondBloxx CCC Rated USD High Yield Corp Bd ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||